Implantable Composite for Local Bioactive Agent Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Medical implants often face issues such as impaired healing and infections due to the recruitment of cellular debris and immune system reactions, and existing implants may not be practical for local delivery of bioactive agents.
Innovation Solution
Implantable composites comprising a resilient biocompatible polymer with a bioactive agent, designed to be applied to medical devices close to the time of use, allowing for controlled release of the agent near the implant site, thereby enhancing implant functionality and reducing complications.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a bioactive agent is incorporated into the implant device during manufacturing, then the implant can deliver the agent locally, but the manufacturing process becomes significantly more complex due to different regulations for drug products versus medical devices
Solution Approach 1:
The system separates the implant device from the bioactive agent delivery function by using a distinct composite material layer. The implant device remains a pure medical device while the composite material, applied separately, provides the drug delivery capability. This segmentation allows each component to be manufactured under appropriate regulations independently.
Solution Approach 2:
The composite material is prepared and applied to the implant device in advance, close to the time of use, rather than requiring complex integrated manufacturing. This preliminary action allows the bioactive agent to be incorporated into the composite material separately, simplifying the overall manufacturing process while maintaining local delivery capability.
2Reliability
If the implant surface is designed to integrate with tissue, then healing is enhanced, but the surface recruits cellular debris and biological material that can become infected
Solution Approach 1:
The composite material provides localized anti-infective properties at the implant surface where tissue integration occurs. By concentrating the bioactive agent with anti-infective capability at the critical interface between implant and tissue, the system maintains enhanced healing through tissue integration while simultaneously protecting against infection at the same location.
Solution Approach 2:
The system converts the harmful effect of cellular debris recruitment into a beneficial outcome by applying the composite material that releases anti-infective agents. These agents transform the infection risk associated with tissue integration into an opportunity for active infection prevention, turning a vulnerability into a protected state.
Data Source
AI summary
Described herein are implantable composites, kits comprising the composites, implant devices comprising the composites, and methods of making and using same, including point of use methods.